AFLAC Stock - Analyst and consensus snapshot on a quiet news day

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 14:03 UTC. Details in the imprint.

AFLAC (US0010551028) draws attention today without a fresh company announcement. Instead, the spotlight is on the latest analyst views and earnings consensus that frame expectations for the insurer’s US-listed stock.

What analysts say today

There is no new rating action from the major global investment banks on AFLAC shares today. The key reference point remains the existing mix of Buy, Hold and Sell recommendations compiled by large financial data providers.

According to a current consensus overview from a leading market-data portal, the average analyst rating on AFLAC lies in the neutral-to-positive range, with only a minority of clearly negative calls and a modest number of Buy recommendations underpinning the stock’s profile.

Consensus on earnings and valuation

Consensus estimates suggest that analysts expect AFLAC to generate stable earnings over the next 12 months, with only limited growth built into current forecasts. That leaves room for positive or negative surprises when the company next updates investors.

On valuation, aggregated data from a major financial website indicates that AFLAC stock trades at a price-to-earnings multiple that is broadly in line with, or slightly below, the average level for large US-listed insurance peers.

How the company makes money

AFLAC’s core business is supplemental health and life insurance, with a particularly strong presence in Japan and a significant footprint in the United States. The group earns premiums from policyholders and invests the resulting float in fixed-income and other assets to generate additional income.

Where the stock trades today

The shares of AFLAC trade on the New York Stock Exchange in US dollars; a precise, up-to-date quote could not be reliably verified at the time of writing.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.